Insiders AMOS Group Limited

Equities

Delayed Singapore S.E. Other stock markets 05:04:11 2024-06-21 EDT			5-day change	1st Jan Change
0.048 ^SGD	-11.11%		-11.11%	-28.36%

06-24	Singapore Bourse Allows Amos Group's Sale of South Korea Property Without Shareholder Approval	MT
05-30	AMOS Group Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Amos Group Appoints CFO	04-02	MT
Amos Group Names Acting CEO	23-09-05	MT
AMOS Group Limited Announces the Promotion of Ronald Broer as Acting Chief Executive Office	23-09-04	CI
Amos Group CFO Resigns	23-07-25	MT
AMOS Group Limited Announces Resignation of G Krishnamurthi as Chief Financial Officer	23-07-24	CI
Amos Group Names CFO	23-01-25	MT
Amos Group CFO Resigns	22-10-14	MT
AMOS Group CEO Steps Down	22-05-20	MT
AMOS Group Limited Announces Resignation of Keith Ian Mullin as Chief Executive Officer, Effective 19 May 2022	22-05-19	CI
AMOS Group's CFO Designate to Take Charge in December	21-11-04	MT
Vascular Biogenics : VBL Therapeutics Names Sam Backenroth Chief Financial Officer	21-10-05	MT
Vascular Biogenics : VBL Therapeutics Appoints Sam Backenroth Chief Financial Officer	21-10-05	MT
AMOS : Names New CFO	21-09-29	MT
Amos Group Limited Announces Board Changes	21-09-12	CI
Tiong Seng : Appoints Non-executive Chairman of Unit	21-09-01	MT
AMOS Group Limited Announces Update on Change in Board Composition and Reconstitution of Board Committees	21-06-15	CI
AMOS Group Limited Announces Change of Company Secretary	21-05-28	CI
AMOS : Names New CEO	21-04-21	MT
AMOS Group Limited Appoints Keith Ian Mullin as Chief Executive Officer, Effective on 15 June 2021	21-04-21	CI
Keith Ian Mullin to Step Down as Independent Non-Executive Director of AMOS Group Limited, Effective 15 June 2021	21-04-21	CI

No results for this search